Interim report January-September 2013: Continuing positive trend
- Organic growth of 8 percent for the quarter in comparable units
- Profits developing well compared with the previous year
- Fourth quarter in a row with improved profits compared with the previous year
THIRD QUARTER 2013
- Revenues increased by 1 percent to SEK 139.7 million (137.8)
- EBITDA amounted to SEK -1.1 million (-4.9)
- The operating result (EBIT) amounted to SEK -8.3 million (-49.8 including goodwill write-downs of SEK -36.8 million)
- The result before tax (EBT) amounted to SEK -12.8 million (-55.0)
- The result after tax (EAT) amounted to SEK -12.0 million (-54.1)
- The result per share amounted to SEK -0.20 (-0.81)
JANUARY – SEPTEMBER 2013
- Revenues increased by 2 percent to SEK 529.3 million (517.5)
- EBITDA amounted to SEK 41.2 million (12.3)
- The operating result (EBIT) amounted to SEK 20.0 million (-50.3 including goodwill write-downs of SEK -36.8 million)
- The result before tax (EBT) amounted to SEK 11.9 million (-59.1)
- The result after tax (EAT) amounted to SEK 8.1 million (-63.7)
- The result per share amounted to SEK 0.05 (-0.98)
THE CEO’S COMMENTS
Global Health Partner, GHP, reports a stronger third quarter this year in terms of both sales and profits. Organic growth amounted to 8 percent during the quarter for comparable units compared with the same period last year. We can thus look back on four quarters with a steady upward trend, which demonstrates improved stability in our business.
The third quarter in the health care business is seasonally weak as hospital clinics are shut for parts of the summer. This is something that also holds back GHP’s sales and profits. Furthermore, we had to close our clinics at Löwenströmska in Stockholm for an extra-long period during the quarter for renovation work. In the light of this we have every reason to be proud of the growth during the third period. Our improved figures for the quarter are largely a result of us working on making our processes more efficient and increasing the patient flow. We are continuing with this work.
Another explanation for our positive development is that more and more people are discovering what good care GHP offers. The patient’s influence over the choice of care provider is becoming greater and greater, not least of all when the patient law that has been proposed by the Patient Power Inquiry comes into effect, whereby patients, no matter where in the country they live, are entitled to choose to be treated or examined in another County Council region. It is our ambition here that these patients come to clinics run by GHP, in the knowledge that they will be given first-class care and will be well looked after.
We are therefore purposefully working on increasing people’s knowledge of GHP, even though we already have strong relations with County Councils and insurance companies. It is increasingly clear in the free choice of health care that those referring patients and the patients themselves become our customers. We want both existing and potential customers to ask to come to a GHP-clinic and we want GHP to be seen as a guarantee of first-class care.
To sum up, we can say that our cornerstone is “Quality through specialisation”, where large patient flows within a specific area give us experience and competence. For us quality is also development, to be driven by the will to be better all the time with regard to our processes, the care we provide and not least patient perception. This perception is strengthened when patients get continuity and can feel genuine commitment when they meet their doctor and other staff at the clinic.
It is precisely the doctor’s and the whole team’s genuine commitment to their patients that I have noticed is a characteristic that is shared by our clinics. It is a strong foundation on which to continue to develop GHP in the future.
30 October 2013
Gothenburg
Global Health Partner AB (publ)
Marianne Dicander Alexandersson
CEO
Queries should be addressed to:
Marianne Dicander Alexandersson, CEO, phone: +46-31 712 53 09
Tobias Linebäck, CFO and Head of Investor Relations, phone: +46-708 55 37 19
Global Health Partner is an internationally active healthcare provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique in the healthcare industry, where leading doctors become partners and shareholders. Multiple clinics with high patient volumes within the same diagnostic area produce increased efficiency and higher quality, which is the cornerstone of Global Health Partner's business philosophy – “Quality through Specialisation”. Global Health Partner’s shares are traded on the Small Cap list at NASDAQ OMX Stockholm under the abbreviation “GHP”.
Global Health Partner AB (publ) | www.globalhealthpartner.com
Corp. ID No. 556757-1103 | Östra Hamngatan 26-28 | SE-411 09 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21
Global Health Partner AB is required to publish the information herein according to the Swedish Securities Market Act. This information was published on 30 October 2013 at 8.00 a.m. CET.
This is a translation of the Swedish version of the interim report. When in doubt, the Swedish wording prevails.
Tags: